About University of Louisville Clinical Trials Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Louisville Clinical Trials Unit
During the past decade, University of Louisville Clinical Trials Unit conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Louisville Clinical Trials Unit" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Galapagos NV" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Intercept Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville Clinical Trials Unit"
#1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at University of Louisville Clinical Trials Unit
According to Clinical.Site data, the most researched conditions in "University of Louisville Clinical Trials Unit" are
"Nonalcoholic Steatohepatitis" (2 trials), "Ulcerative Colitis" (2 trials), "Atrial Fibrillation" (1 trials), "COVID-19 Prevention" (1 trials) and "Combined Pulmonary Fibrosis and Emphysema" (1 trials). Many other conditions were trialed in "University of Louisville Clinical Trials Unit" in a lesser frequency.
Clinical Trials Intervention Types at University of Louisville Clinical Trials Unit
Most popular intervention types in "University of Louisville Clinical Trials Unit" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Filgotinib" (4 trials), "Apixaban" (1 trials), "Inhaled Treprostinil" (1 trials) and "Obeticholic acid (10 mg to 25 mg)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Louisville Clinical Trials Unit
The vast majority of trials in "University of Louisville Clinical Trials Unit" are
11 trials for "All" genders.
Clinical Trials Status at University of Louisville Clinical Trials Unit
Currently, there are NaN active trials in "University of Louisville Clinical Trials Unit".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 7 completed trials in University of Louisville Clinical Trials Unit,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Louisville Clinical Trials Unit, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".